|
Volumn 17, Issue SUPPL. F, 1996, Pages 9-15
|
The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials
|
Author keywords
Acute myocardial infarction; Reteplase; Thrombolytics; Tissue plasminogen activator
|
Indexed keywords
ALTEPLASE;
FIBRINOLYTIC AGENT;
RETEPLASE;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
ACUTE HEART INFARCTION;
BLEEDING;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTINUOUS INFUSION;
CORONARY ARTERY BLOOD FLOW;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
FIBRINOLYTIC THERAPY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
META ANALYSIS;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
STROKE;
SURVIVAL;
|
EID: 0029819362
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/eurheartj/17.suppl_f.9 Document Type: Conference Paper |
Times cited : (21)
|
References (0)
|